Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis–HIV-co-infected patients in resource-constrained settings.
Loading...
Date
2005
Journal Title
Journal ISSN
Volume Title
Publisher
Lippincott Williams & Wilkins.
Abstract
No abstract available.
Description
Correspondence
Keywords
Highly active antiretroviral treatment., HIV infections--Treatment., Tuberculosis--Treatment.
Citation
Gray, A.L., Abdool Karim, S.S. & Gengiah, T.N. 2006. Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis–HIV-co-infected patients in resource-constrained settings. AIDS 20(2) pp. 302-303.